In SARS-CoV-2 positive patients, patients using immunosuppressive drugs prior to COVID-19 had significantly lower CD4+ T-lymphocyte counts, but no differences in lymphocyte subsets were found between mild and severe cases. This evidence concerns the gene CD4 and COVID-19.